efanesoctocog alfa
SpainDrugs containing this active substance
-
It is used to treat and prevent bleeding episodes in people with hemophilia A, a hereditary disorder caused by a deficiency or malfunction of factor VIII.
Form: powder and solvent for solution for injection
Active substance Dosage efanesoctocog alfa 1000 UI Manufacturer: Swedish Orphan Biovitrum Ab (Publ)
-
It is used to treat and prevent bleeding episodes in people with hemophilia A, a hereditary disorder caused by a deficiency or dysfunction of factor VIII.
Form: powder and solvent for solution for injection
Active substance Dosage efanesoctocog alfa 2000 UI Manufacturer: Swedish Orphan Biovitrum Ab (Publ)
-
It is used to treat and prevent bleeding episodes in patients with hemophilia A, a hereditary disorder caused by a deficiency or malfunction of factor VIII.
Form: powder and solvent for solution for injection
Active substance Dosage efanesoctocog alfa 250 UI Manufacturer: Swedish Orphan Biovitrum Ab (Publ)
-
It is used to treat and prevent bleeding episodes in patients with hemophilia A, a hereditary disorder caused by the deficiency or dysfunction of factor VIII.
Form: powder and solvent for solution for injection
Active substance Dosage efanesoctocog alfa 3000 UI Manufacturer: Swedish Orphan Biovitrum Ab (Publ)
-
It is used to treat and prevent bleeding episodes in patients with hemophilia A, a hereditary disorder caused by a deficiency or malfunction of factor VIII.
Form: powder and solvent for solution for injection
Active substance Dosage efanesoctocog alfa 4000 UI Manufacturer: Swedish Orphan Biovitrum Ab (Publ)
-
It is used to treat and prevent bleeding episodes in patients with hemophilia A, a hereditary disorder caused by a deficiency or dysfunction of factor VIII.
Form: powder and solvent for solution for injection
Active substance Dosage efanesoctocog alfa 500 UI Manufacturer: Swedish Orphan Biovitrum Ab (Publ)